1 min read
Accendra Health Extends $150 Million Receivables Sale Program to October 2029
Shares were up nearly 21% in premarket trading to $0.31 on Nov. 2.

Accendra Health, Inc. (ACH) extended the scheduled end date for its $150 million receivables sale program to October 2029, while retaining the existing program amount.
The program’s size remains unchanged. Shares were up nearly 21% in premarket trading to $0.31 on Nov. 2.